State Street Corp grew its holdings in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) by 1.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,401,953 shares of the company's stock after buying an additional 18,304 shares during the quarter. State Street Corp owned 2.16% of Concentrix worth $71,850,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. GSA Capital Partners LLP purchased a new stake in shares of Concentrix during the 3rd quarter valued at about $1,243,000. Raymond James & Associates raised its stake in shares of Concentrix by 73.3% during the third quarter. Raymond James & Associates now owns 55,313 shares of the company's stock valued at $2,835,000 after purchasing an additional 23,387 shares during the period. State of Alaska Department of Revenue lifted its position in shares of Concentrix by 24.8% during the third quarter. State of Alaska Department of Revenue now owns 64,783 shares of the company's stock worth $3,319,000 after purchasing an additional 12,870 shares in the last quarter. Intech Investment Management LLC acquired a new position in shares of Concentrix during the third quarter worth $1,255,000. Finally, Sanders Morris Harris LLC purchased a new position in shares of Concentrix in the third quarter valued at $2,562,000. Institutional investors and hedge funds own 90.34% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on the stock. Baird R W raised shares of Concentrix to a "strong-buy" rating in a research note on Thursday, October 3rd. Canaccord Genuity Group dropped their target price on Concentrix from $125.00 to $100.00 and set a "buy" rating on the stock in a research report on Thursday, September 26th. Bank of America reduced their price target on Concentrix from $85.00 to $70.00 and set a "neutral" rating for the company in a report on Thursday, September 26th. Robert W. Baird started coverage on Concentrix in a report on Thursday, October 3rd. They set an "outperform" rating and a $70.00 price objective on the stock. Finally, Barrington Research reduced their target price on Concentrix from $84.00 to $70.00 and set an "outperform" rating for the company in a research note on Thursday, September 26th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $79.00.
Read Our Latest Research Report on Concentrix
Insider Activity
In related news, CEO Christopher A. Caldwell sold 9,823 shares of the business's stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $52.70, for a total transaction of $517,672.10. Following the completion of the transaction, the chief executive officer now owns 241,841 shares in the company, valued at $12,745,020.70. The trade was a 3.90 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Cormac J. Twomey sold 1,544 shares of the company's stock in a transaction on Monday, September 30th. The stock was sold at an average price of $51.38, for a total value of $79,330.72. Following the transaction, the executive vice president now owns 27,783 shares of the company's stock, valued at approximately $1,427,490.54. The trade was a 5.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 12,367 shares of company stock valued at $641,668. Company insiders own 3.10% of the company's stock.
Concentrix Stock Down 5.9 %
Concentrix stock traded down $2.47 during midday trading on Wednesday, hitting $39.69. The stock had a trading volume of 664,307 shares, compared to its average volume of 578,395. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.18. The business has a fifty day moving average price of $43.90 and a 200 day moving average price of $57.22. Concentrix Co. has a 12 month low of $36.28 and a 12 month high of $106.10. The stock has a market cap of $2.57 billion, a P/E ratio of 12.89, a P/E/G ratio of 0.56 and a beta of 0.63.
Concentrix (NASDAQ:CNXC - Get Free Report) last posted its quarterly earnings results on Wednesday, September 25th. The company reported $2.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.93 by ($0.06). The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.38 billion. Concentrix had a net margin of 2.18% and a return on equity of 16.57%. The business's revenue was up 46.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.54 earnings per share. Research analysts predict that Concentrix Co. will post 10.18 EPS for the current year.
Concentrix Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 5th. Stockholders of record on Friday, October 25th were issued a $0.333 dividend. The ex-dividend date was Friday, October 25th. This is a positive change from Concentrix's previous quarterly dividend of $0.30. This represents a $1.33 annualized dividend and a dividend yield of 3.36%. Concentrix's payout ratio is 43.18%.
Concentrix Profile
(
Free Report)
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Featured Articles
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.